Administration of Bifidobacterium breve PS12929 and Lactobacillus salivarius PS12934, Two Strains Isolated from Human Milk, to Very Low and Extremely Low Birth Weight Preterm Infants: A Pilot Study
Table 2
Frequency and concentration of immune compounds in fecal samples () along time.
Day 0 ()
Day 7 ()
Day 14 ()
value*
(%)
Median (IQR)
(%)
Median (IQR)
(%)
Median (IQR)
(mg/kg)
(mg/kg)
(mg/kg)
Immunoglobulins
IgG1
5 (100)
3.95 (1.23–6.36)
4 (100)
0.45 (0.23–0.80)
5 (100)
1.26 (0.47–2.43)
0.819
IgG2
5 (100)
23.82 (23.19–24.17)
4 (100)
2.98 (2.46–3.97)
5 (100)
2.66 (2.60–3.62)
0.074
IgG3
4 (80)
0.02 (0.01–0.02)
1 (25)
0.01 (0.01–0.01)
2 (40)
0.22 (0.11–0.32)
0.424
IgG4
5 (100)
0.03 (0.02–0.14)
4 (100)
0.02 (0.01–0.03)
5 (100)
0.03 (0.00–0.06)
0.449
IgM
4 (80)
2.72 (0.19–8.73)
3 (75)
1.10 (0.87–6.00)
5 (100)
2.79 (0.44–10.02)
0.819
IgA
5 (100)
3.57 (0.88–21.73)
4 (100)
201.23 (35.09–356.74)
5 (100)
7.49 (2.96–7.78)
0.074
(ng/kg)
(ng/kg)
(ng/kg)
Proinflammatory
Calprotectin
5 (100)
309.50 (282.00–343.90)
4 (100)
144.80 (132.30–180.40)
5 (100)
38.42 (34.16–63.96)
0.041
1 (20)
31.47
3 (75)
41.34 (8.00–74.68)
3 (60)
39.20 (−36.24–114.64)
0.937
IL-2
1 (20)
8.47
1 (25)
8.18
0 (0)
—
0.368
IL-6
0 (0)
—
0 (0)
—
1 (20)
27.44
0.368
IL-12 (p70)
2 (40)
29.07 (28.82–29.32)
2 (50)
37.13 (36.38–37.89)
1 (20)
82.98
0.926
IL-17
2 (40)
72.94 (62.76–83.11)
2 (50)
66.08 (64.46–67.71)
2 (40)
69.31 (65.15–73.48)
1.000
IFN-γ
4 (80)
214.90 (190.40–238.30)
4 (100)
299.80 (255.40–320.80)
4 (80)
248.10 (215.80–265.50)
0.449
TNF-α
1 (20)
20.87
0 (0)
—
0 (0)
—
0.368
(ng/kg)
(ng/kg)
(ng/kg)
Anti-inflammatory
IL-4
3 (60)
2.74 (2.43–3.48)
4 (100)
2.63 (2.49–2.85)
3 (60)
2.12 (2.06–2.26)
0.268
IL-5
0 (0)
—
0 (0)
—
0 (0)
—
—
IL-10
1 (20)
25.62
2 (50)
37.21 (35.85–38.57)
3 (60)
39.20 (38.66–53.87)
0.319
IL-13
0 (0)
—
0 (0)
—
0 (0)
—
—
(ng/kg)
(ng/kg)
(ng/kg)
Chemokines
IL-8
4 (80)
20.94 (19.00–23.82)
3 (75)
16.16 (15.56–17.20)
2 (40)
17.05 (16.45–17.64)
0.128
GRO-α
5 (100)
206.30 (117.04–295.57)
3 (75)
222.10 (−77.61–521.80)
4 (80)
263.50 (261.05–265.88)
0.763
MCP-1
5 (100)
20.08 (15.02–28.89)
2 (50)
18.37 (16.82–19.93)
3 (60)
16.98 (14.21–17.34)
0.076
MIP-1β
5 (100)
53.79 (52.03–68.66)
4 (100)
58.16 (46.46–66.42)
4 (80)
49.60 (35.16–69.89)
0.449
(ng/kg)
(ng/kg)
(ng/kg)
Haematopoietic stimuli
IL-7
0 (0)
—
0 (0)
—
0 (0)
—
—
G-CSF
1 (20)
28.99
0 (0)
—
0 (0)
—
0.368
GM-CSF
5 (100)
1729.00 (1086.00–2312.00)
4 (100)
1830.00 (1648.00–2010.00)
4 (80)
1879.00 (1783.00–1920.00)
0.819
Levels of immune compounds were expressed as median and interquartile range (IQR) when data were not normally distributed and as mean and 95% confidence interval (95% CI) when they were. *Friedman test was used to determine the differences between fecal samples along time when data were not normally distributed and one-way ANOVA when they were. †Concentration was expressed as ng/Kg of feces for all the proinflammatory parameters with the exception of calprotectin whose units were mg/Kg. Normally distributed.